IBT
RIGL icon

International Biotechnology Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

International Biotechnology Trust’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-37,000
Closed -$1.04M – 53
2018
Q2 		$1.04M Hold
37,000
– – 0.4% 45
2018
Q1 		$1.3M Buy
+37,000
New +$1.48M 0.51% 44

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

International Biotechnology Trust's RIGL Position: Q3 2018 in Review

International Biotechnology Trust sold out of Rigel Pharmaceuticals (RIGL) in Q3 2018, closing a stake of 37,000 shares — an estimated $1.04M sold.

International Biotechnology Trust first reported a position in RIGL in Q1 2018 and held it in 2 quarters. The position peaked at $1.3M in Q1 2018. 135 funds tracked by Wall St. Rank hold RIGL as of Q3 2018.

  • International Biotechnology Trust reported no remaining Rigel Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 37,000 Rigel Pharmaceuticals shares in Q3 2018, an estimated $1.04M.
  • International Biotechnology Trust first reported a position in Rigel Pharmaceuticals in Q1 2018 and held it in 2 quarters.
  • International Biotechnology Trust's Rigel Pharmaceuticals position peaked at $1.3M in Q1 2018.
  • 135 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2018.

Based on International Biotechnology Trust's 13F filing for Q3 2018, filed 13 Nov 2018.